Pharmacy Question for the Week of February 3, 2020

Pharmacy Compliance Question of the Week


What is the ASP rate for nonpass-through drugs in 2020?


According to the Centers for Medicare & Medicaid Services (CMS), for 2020, payment for nonpass-through drugs that were not acquired through the 340B Program will be made at a single rate of ASP + 6 percent (or ASP + 6 percent of the reference product for biosimilars).